News

According to investigators, recent trial results indicate no other biologic treatment has shown as rapid onset than benralizumab for patients with eosinophilic asthma.

The CNS stimulant was approved as an extended-released capsule intended to serve as a first-line ADHD therapy.

Analysis of multiple studies demonstrates glecaprevir/pibrentasvir pangenotypic HCV efficacy despite concurrent gastric acid-reducing drugs.

A study suggests individuals who received egg-based flu vaccines had less protection against circulating strains of influenza than those with cell-based vaccines in the 2017-2018 season.

By identifying epitopes that are common to all types of the flu, researchers believe they may have created a pathway to a universal flu vaccine.

The 100 Units/mL/ 300 mcg/mL-dosed therapy was previously approved as an add-on therapy to diet and exercise in adults with T2D.

The new guideline centers on the overall diagnosis, management, and clinical treatment of the chronic inflammatory disease.

There has been a debate about whether retina specialists under-treat with anti-VEGF therapy in the real-world setting.

Investigators found an association between disease progression change in done dark adaptation, yellow-blue, chromatic threshold and foveal thickness.

The loteprednol etabonate ophthalmic gel 0.38% was proven efficacious and safe in a pair of double-masked trials, and will reach the market by April 2019.

New research based on 8 flu seasons’ worth of data supports the early use of oseltamivir, particularly in cases of A(H3N2) influenza.

The investigators also examined patients who had 3 or more injections in the year prior to their cardiac event.

Anxiety and depression each contribute to impaired cognition in patients with MS and other immune-mediated disorders, a new study shows.

Direct-acting antiviral treatment of HCV prior to liver transplant does not increase pre-transplant liver cancer progression or post-transplant recurrence.

As people age, their B cells become less adaptive, leaving them more susceptible to the flu.

A new CMS-based study reports that annual healthcare spending growth should exceed an average of 5%, and that spending will shift from private to Medicare.

Behavioral model predicts when MS patients decline treatment for delayed or insufficient benefit, and the probability and severity of side effects.

Female sex on its own was a risk for arrhythmic events, but only for certain LQTS genotypes.

The intranasal epinephrine spray is being developed for use with Intravail, a nasal absorption enhancing technology.

The first prospective, longitudinal study of direct-acting antivirals for HCV finds that treatment reduces risks of all-cause mortality and liver cancer.

Each flu season, the race is on to determine how well the flu vaccine is working. But researchers caution that many of the studies used to calculate effectiveness have potential pitfalls.

FDA trial approval would make this trial the first ever to test a stem cell-based therapy derived from induced pluripotent stem cells for treating any disease.

An investigational non-opioid pain medication, tanezumab demonstrated statistically significant pain reduction at 16 weeks compared to placebo.

The Novo Nordisk drug has been granted approved with supporting evidence from a 270-patient assessment—the largest pre-registration clinical program ever conducted in the hemophilia A field.

A new analysis of an ongoing clinical study offers insights for treating retinal vein occlusion in poor responders to bevacizumab.

William Lennarz, MD, touches on unique aspects of a pediatric ER, including staffing, equipment needs, medication dosing, and working with EMS to improve children's experiences.

Characterizing these pediatric epilepsy readmissions is the first step in reducing readmissions, study authors said.

Asthma risk and lung disease development can occur as easily and as frequently with smoking alternatives as it does with combustible cigarettes.